Compliance Tip of the Day: Rethinking Corporate AI Governance Through Design Intelligence
Daily Compliance News: July 22, 2025, The I-9 Hell Edition
Compliance Tip of the Day: Avoiding CCO Liability
Compliance Tip of the Day: COSO Governance Framework - Part 5, People
SkadBytes Podcast | Tech’s Shifting Landscape: Five Trends Shaping the Conversation
Balch’s Consumer Finance Compass: How Standing Can Make or Break Certification for Class Action Lawsuits in Debt Collection
Top challenges with Compliance Management
Innovation in Compliance: Allison Lagosh on Proactive Compliance Planning for Regulatory Changes
Daily Compliance News: July 15, 2025, The Fighting Workplace Bullying Edition
Compliance Tip of the Day: Design - Centric Internal Controls
Treating Compliance Like an Asset
When DEI Meets the FCA: What Employers Need to Know About the DOJ’s Civil Rights Fraud Initiative
#Risk New York Speaker Series – Exploring Future Regulatory Trends and Compliance Strategies with Rory McGrath
The Capital Ratio Podcast | Entering the US Banking Market
SCOTUS Clean Air Act Cases: What’s New?
First 100 Days of the New HSR Rules with Antitrust Partner Kara Kuritz
Hospice Insights Podcast - Election Inspection: Be Proactive to Avoid Costly Election Statement Denials
From Permits to Penalties: A Deep Dive Into Coastal Development Law
Compliance into the Weeds: Boeing’s New Safety Initiatives and Compliance Reforms
PODCAST: Williams Mullen's Benefits Companion - Gag Clause Prohibitions
Finally, after providing the building blocks for strong Information Governance (IG) programs and operationalizing that framework, we discuss how to sustain your IG program in the last part of the series. An effective IG...more
In October 2022, the UK legal system marked a significant evolution in its approach to disclosure with the implementation of Practice Direction 57AD (PD57AD). This directive, applicable to the Business and Property Courts of...more
The European Medicines Agency (EMA) published a workplan on its ambition to leverage high volumes of data and artificial intelligence (AI). On 7 May 2025, the European Medicines Agency (EMA) published a joint workplan with...more
ComplexDiscovery Editor’s Note: The 1H 2025 eDiscovery Business Confidence Survey marks the 37th edition of this trusted industry snapshot, drawing insights from 77 professionals across the legal, technology, and corporate...more
On April 9 2025, the European Commission published the AI Continent Action Plan (the Action Plan), which outlines the EU’s strategy to enhance innovation, competitiveness and regulatory compliance in artificial intelligence...more
The European Commission’s AI Office (the overarching body overseeing enforcement of the EU AI Act) published its AI Continent Action Plan on April 9, 2025 (“Plan”). In this Plan, the European Commission (“EC”) puts forward...more
While positioning itself as a global leader in artificial intelligence (AI) regulation with the EU AI Act, the EU has not historically been a global leader in innovative AI achievements. American and Chinese companies have...more
Bennett Borden, founder and CEO of Clarion AI Partners, sits down with Kaylee and Mary to share his journey from the CIA to law school and BigLaw eDiscovery, to his decision to refresh his data skills at NYU. Bennett...more
With new collaboration features, AI tools, and work technology developing at a dizzying pace, we know that the volume of data organizations must manage will only increase faster. What are the risks and costs involved with...more
Artificial intelligence (AI), particularly generative AI, thrives on vast amounts of data, fueling AI capabilities, insights, and predictions. But with this reliance on data comes potential privacy and security risks. And...more
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial intelligence (AI): Artificial Intelligence-Enabled Device Software Functions: Lifecycle...more
Artificial Intelligence has rapidly moved from theoretical to transformational, profoundly changing how businesses operate across industries. While the benefits of AI, particularly Generative AI (genAI), are monumental, these...more
In the waning days of the Biden administration, the FDA released a flood of new guidance documents and other agency actions, including several important items related to digital health. On January 7, FDA published two new...more
The Food and Drug Administration (FDA) has recently issued two draft guidance documents aimed at providing recommendations for the use of AI in medical devices and drug and biological product development.These guidance...more
Looking for something more advanced than your average export controls conference? Go beyond the basics at ACI’s 2nd Annual Advanced Forum on Global Export Controls. This premier event offers cutting-edge insights and...more
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s safety, effectiveness, or...more
The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations and...more
On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations,” which...more
On January 7, 2025, FDA published “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff”...more
On January 7, 2025, FDA published a draft guidance titled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.” The draft guidance was long-anticipated; it...more
The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices. The Importance of Engaging Early Sponsors of AI-enabled devices should engage with the...more
In the rapid evolution of artificial intelligence, companies are often enticed by the numerous benefits that AI can offer, from improving efficiency and productivity to gaining a competitive edge....more
AI is accelerating digital transformation for companies and data governance is a key pillar in this change, enabling data strategies that unlock the potential of AI, and mitigate the risks associated with its use. Data...more
The enactment of Brazil's proposed AI Regulation remains uncertain with compliance requirements pending review. Laws/Regulations directly regulating AI (the “AI Regulations”) Brazil intends to regulate AI through Bill...more
The EU recently introduced the AI Act, landmark legislation aimed at regulating artificial intelligence (AI) technologies. This article provides an in-depth overview of the EU AI Act, its implications for organizations, and...more